Share Price and Basic Stock Data
Last Updated: December 24, 2025, 3:43 am
| PEG Ratio | -3.44 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Arex Industries Ltd operates within the textiles processing and texturizing sector, showcasing a significant growth trajectory in its revenue streams. For the fiscal year ending March 2025, the company reported a total sales figure of ₹51.14 Cr, a slight increase from ₹51.01 Cr in the previous fiscal year. Over the last few quarters, sales have shown positive momentum, increasing from ₹10.96 Cr in September 2022 to ₹12.80 Cr in September 2023. This upward trend in quarterly sales reflects a robust demand for its textile products, with the highest quarterly sales recorded at ₹13.05 Cr in December 2023. The company’s ability to maintain operational efficiency is evident, as sales per share rose to ₹142.11 in March 2025, compared to ₹128.86 in March 2024. This consistent revenue growth positions Arex Industries favorably within the competitive textile landscape, potentially enhancing its market share and operational scale.
Profitability and Efficiency Metrics
Arex Industries Ltd demonstrated commendable profitability metrics, with a net profit of ₹2.63 Cr for the fiscal year ending March 2025, up from ₹2.54 Cr in the preceding year. The company’s net profit margin stood at 5.15% for March 2025, indicating effective cost management and pricing strategies. Operating Profit Margin (OPM) reported at 15.94% for the same period reflects operational efficiency, although it has seen fluctuations, peaking at 26.97% in December 2023. The Interest Coverage Ratio (ICR) of 8.13x showcases the company’s strong ability to meet its interest obligations, further bolstered by a Return on Equity (ROE) of 10.26% for March 2025. The Cash Conversion Cycle (CCC) improved to 138.57 days, indicating enhanced efficiency in managing working capital. However, the fluctuating OPM and net profit margins suggest that the company faces challenges in sustaining profitability across varying market conditions.
Balance Sheet Strength and Financial Ratios
Arex Industries maintains a balanced and resilient financial position, with total assets reported at ₹46.63 Cr as of March 2025. The company’s borrowings have decreased significantly from ₹17.75 Cr in March 2023 to ₹12.34 Cr in March 2025, indicating effective debt management. With a Debt to Equity ratio of 0.48, Arex is well within typical sector norms, suggesting a conservative capital structure. Additionally, reserves stood at ₹22.07 Cr, providing a cushion against market volatility. The Book Value per Share was ₹71.34 for March 2025, reflecting solid equity backing. The company’s Return on Capital Employed (ROCE) of 11.76% indicates efficient utilization of capital in generating profits. However, the declining trend in total assets from ₹58.46 Cr in March 2022 to ₹46.63 Cr in March 2025 raises concerns about the company’s asset management strategies, necessitating a closer examination of its investment decisions.
Shareholding Pattern and Investor Confidence
Arex Industries’ shareholding structure reveals a strong promoter backing, with promoters holding 70.60% of the total equity as of September 2025. This level of control may instill confidence among investors regarding the company’s strategic direction. The number of shareholders has shown minor fluctuations, with a total of 2,380 shareholders reported in September 2025, down from 2,641 in September 2024. This decline may reflect a consolidation phase, which could be interpreted as either a positive sign of investor confidence or a cautionary signal regarding liquidity. Public shareholding stood at 29.38%, suggesting limited free float in the market. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) indicates a potential opportunity for increased institutional interest, which could drive liquidity and valuation. The stability in promoter holdings over recent quarters suggests a commitment to long-term growth, which is a positive signal for potential investors.
Outlook, Risks, and Final Insight
Looking ahead, Arex Industries Ltd is positioned to capitalize on its growing revenue trends and profitability metrics; however, it faces certain risks. The textile industry is prone to cyclical demand fluctuations, and the company’s recent decline in total assets could hinder future growth if not addressed. Moreover, the volatility in operating margins poses a challenge to consistent profitability. On the other hand, the strong promoter backing and improved efficiency metrics provide a solid foundation for potential growth. Should the company successfully manage its asset utilization and maintain its operational efficiency, it could enhance shareholder value significantly. Additionally, attracting institutional investors could further bolster liquidity and market perception. Overall, while there are risks to monitor, Arex Industries’ current financial health and growth trajectory present a cautiously optimistic outlook for stakeholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minaxi Textiles Ltd | 7.66 Cr. | 1.55 | 2.51/1.41 | 3.99 | 0.82 | 0.00 % | 2.20 % | 42.3 % | 1.00 |
| Gujarat Cotex Ltd | 11.6 Cr. | 8.11 | 20.0/6.72 | 17.5 | 5.36 | 0.00 % | 3.59 % | 3.26 % | 5.00 |
| Gini Silk Mills Ltd | 34.8 Cr. | 62.2 | 141/61.4 | 19.1 | 91.2 | 0.00 % | 3.23 % | 2.24 % | 10.0 |
| Dhanlaxmi Fabrics Ltd | 47.2 Cr. | 55.0 | 70.5/50.6 | 53.1 | 0.00 % | 8.07 % | 8.90 % | 10.0 | |
| Bluechip Tex Industries Ltd | 25.8 Cr. | 131 | 189/120 | 130 | 0.00 % | 4.77 % | 5.30 % | 10.0 | |
| Industry Average | 1,264.29 Cr | 123.91 | 79.85 | 81.67 | 0.31% | 11.05% | 12.54% | 7.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.96 | 11.19 | 10.87 | 11.68 | 12.80 | 13.05 | 13.48 | 12.97 | 12.34 | 13.20 | 12.64 | 11.27 | 13.01 |
| Expenses | 9.71 | 9.26 | 9.40 | 9.82 | 10.40 | 9.53 | 12.16 | 10.48 | 10.97 | 10.62 | 10.88 | 9.57 | 10.38 |
| Operating Profit | 1.25 | 1.93 | 1.47 | 1.86 | 2.40 | 3.52 | 1.32 | 2.49 | 1.37 | 2.58 | 1.76 | 1.70 | 2.63 |
| OPM % | 11.41% | 17.25% | 13.52% | 15.92% | 18.75% | 26.97% | 9.79% | 19.20% | 11.10% | 19.55% | 13.92% | 15.08% | 20.22% |
| Other Income | 0.00 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.65 | 0.00 | 0.04 | 0.00 | 0.00 |
| Interest | 0.49 | 0.45 | 0.36 | 0.40 | 0.36 | 0.32 | 0.25 | 0.26 | 0.16 | 0.35 | 0.32 | 0.29 | 0.29 |
| Depreciation | 1.08 | 1.08 | 1.00 | 1.07 | 1.10 | 1.08 | 0.91 | 1.00 | 1.00 | 1.00 | 1.13 | 1.06 | 1.06 |
| Profit before tax | -0.32 | 0.42 | 0.18 | 0.39 | 0.94 | 2.12 | 0.25 | 1.23 | 0.86 | 1.23 | 0.35 | 0.35 | 1.28 |
| Tax % | -21.88% | 28.57% | 0.00% | 28.21% | 18.09% | 30.66% | 88.00% | 32.52% | 33.72% | 20.33% | 25.71% | 25.71% | 21.09% |
| Net Profit | -0.25 | 0.29 | 0.17 | 0.28 | 0.77 | 1.47 | 0.03 | 0.83 | 0.57 | 0.98 | 0.26 | 0.25 | 1.00 |
| EPS in Rs | -0.63 | 0.73 | 0.43 | 0.71 | 1.95 | 3.71 | 0.08 | 2.10 | 1.58 | 2.72 | 0.72 | 0.69 | 2.78 |
Last Updated: December 28, 2025, 2:34 am
Below is a detailed analysis of the quarterly data for Arex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 13.01 Cr.. The value appears strong and on an upward trend. It has increased from 11.27 Cr. (Jun 2025) to 13.01 Cr., marking an increase of 1.74 Cr..
- For Expenses, as of Sep 2025, the value is 10.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.57 Cr. (Jun 2025) to 10.38 Cr., marking an increase of 0.81 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.63 Cr.. The value appears strong and on an upward trend. It has increased from 1.70 Cr. (Jun 2025) to 2.63 Cr., marking an increase of 0.93 Cr..
- For OPM %, as of Sep 2025, the value is 20.22%. The value appears strong and on an upward trend. It has increased from 15.08% (Jun 2025) to 20.22%, marking an increase of 5.14%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.29 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.29 Cr..
- For Depreciation, as of Sep 2025, the value is 1.06 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.28 Cr.. The value appears strong and on an upward trend. It has increased from 0.35 Cr. (Jun 2025) to 1.28 Cr., marking an increase of 0.93 Cr..
- For Tax %, as of Sep 2025, the value is 21.09%. The value appears to be improving (decreasing) as expected. It has decreased from 25.71% (Jun 2025) to 21.09%, marking a decrease of 4.62%.
- For Net Profit, as of Sep 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.25 Cr. (Jun 2025) to 1.00 Cr., marking an increase of 0.75 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.78. The value appears strong and on an upward trend. It has increased from 0.69 (Jun 2025) to 2.78, marking an increase of 2.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:12 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31.70 | 33.04 | 32.15 | 34.94 | 37.66 | 40.72 | 47.17 | 40.88 | 53.75 | 45.02 | 51.01 | 51.14 | 50.12 |
| Expenses | 23.16 | 25.22 | 24.44 | 26.45 | 29.62 | 31.10 | 37.89 | 34.02 | 42.53 | 38.20 | 41.93 | 42.99 | 41.45 |
| Operating Profit | 8.54 | 7.82 | 7.71 | 8.49 | 8.04 | 9.62 | 9.28 | 6.86 | 11.22 | 6.82 | 9.08 | 8.15 | 8.67 |
| OPM % | 26.94% | 23.67% | 23.98% | 24.30% | 21.35% | 23.62% | 19.67% | 16.78% | 20.87% | 15.15% | 17.80% | 15.94% | 17.30% |
| Other Income | -0.13 | 0.08 | 0.06 | -0.06 | 0.11 | 0.42 | 0.15 | 0.08 | 0.04 | 0.23 | 0.10 | 0.74 | 0.04 |
| Interest | 1.07 | 0.77 | 0.72 | 1.02 | 1.09 | 2.54 | 3.13 | 2.98 | 2.11 | 1.81 | 1.33 | 1.09 | 1.25 |
| Depreciation | 4.05 | 3.13 | 2.54 | 2.51 | 2.54 | 4.02 | 4.85 | 4.76 | 4.49 | 4.23 | 4.16 | 4.13 | 4.25 |
| Profit before tax | 3.29 | 4.00 | 4.51 | 4.90 | 4.52 | 3.48 | 1.45 | -0.80 | 4.66 | 1.01 | 3.69 | 3.67 | 3.21 |
| Tax % | 33.13% | 32.50% | 36.36% | 34.29% | 23.67% | 27.59% | 38.62% | 25.00% | 20.60% | 30.69% | 31.17% | 28.07% | |
| Net Profit | 2.20 | 2.69 | 2.87 | 3.22 | 3.45 | 2.52 | 0.88 | -1.00 | 3.70 | 0.70 | 2.54 | 2.63 | 2.49 |
| EPS in Rs | 5.56 | 6.80 | 7.25 | 8.13 | 8.71 | 6.37 | 2.22 | -2.53 | 9.35 | 1.77 | 6.42 | 7.31 | 6.91 |
| Dividend Payout % | 16.20% | 13.25% | 41.39% | 24.60% | 22.96% | 31.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.27% | 6.69% | 12.20% | 7.14% | -26.96% | -65.08% | -213.64% | 470.00% | -81.08% | 262.86% | 3.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | -15.58% | 5.50% | -5.05% | -34.10% | -38.12% | -148.56% | 683.64% | -551.08% | 343.94% | -259.31% |
Arex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -2% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | -11% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | -13% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:24 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.60 | 3.60 |
| Reserves | 10.53 | 12.79 | 14.23 | 17.67 | 20.21 | 21.76 | 21.69 | 20.70 | 24.41 | 25.11 | 27.65 | 22.07 | 23.32 |
| Borrowings | 8.85 | 5.57 | 10.30 | 12.97 | 29.96 | 35.38 | 32.00 | 31.06 | 23.32 | 17.75 | 10.49 | 12.34 | 10.72 |
| Other Liabilities | 3.67 | 2.80 | 4.99 | 3.39 | 5.35 | 6.42 | 6.53 | 6.94 | 6.77 | 5.88 | 8.06 | 8.62 | 8.16 |
| Total Liabilities | 27.01 | 25.12 | 33.48 | 37.99 | 59.48 | 67.52 | 64.18 | 62.66 | 58.46 | 52.70 | 50.16 | 46.63 | 45.80 |
| Fixed Assets | 15.07 | 13.68 | 17.68 | 20.15 | 17.78 | 46.36 | 43.21 | 39.41 | 36.14 | 33.39 | 30.36 | 26.99 | 24.85 |
| CWIP | 0.35 | 0.00 | 1.80 | 0.00 | 23.85 | 0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.03 | 0.88 | 2.61 |
| Investments | 0.02 | 0.03 | 1.03 | 1.26 | 0.12 | 0.02 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 11.57 | 11.41 | 12.97 | 16.58 | 17.73 | 21.14 | 20.97 | 22.24 | 21.83 | 19.31 | 19.77 | 18.76 | 18.34 |
| Total Assets | 27.01 | 25.12 | 33.48 | 37.99 | 59.48 | 67.52 | 64.18 | 62.66 | 58.46 | 52.70 | 50.16 | 46.63 | 45.80 |
Below is a detailed analysis of the balance sheet data for Arex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.60 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.60 Cr..
- For Reserves, as of Sep 2025, the value is 23.32 Cr.. The value appears strong and on an upward trend. It has increased from 22.07 Cr. (Mar 2025) to 23.32 Cr., marking an increase of 1.25 Cr..
- For Borrowings, as of Sep 2025, the value is 10.72 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 12.34 Cr. (Mar 2025) to 10.72 Cr., marking a decrease of 1.62 Cr..
- For Other Liabilities, as of Sep 2025, the value is 8.16 Cr.. The value appears to be improving (decreasing). It has decreased from 8.62 Cr. (Mar 2025) to 8.16 Cr., marking a decrease of 0.46 Cr..
- For Total Liabilities, as of Sep 2025, the value is 45.80 Cr.. The value appears to be improving (decreasing). It has decreased from 46.63 Cr. (Mar 2025) to 45.80 Cr., marking a decrease of 0.83 Cr..
- For Fixed Assets, as of Sep 2025, the value is 24.85 Cr.. The value appears to be declining and may need further review. It has decreased from 26.99 Cr. (Mar 2025) to 24.85 Cr., marking a decrease of 2.14 Cr..
- For CWIP, as of Sep 2025, the value is 2.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.88 Cr. (Mar 2025) to 2.61 Cr., marking an increase of 1.73 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 18.34 Cr.. The value appears to be declining and may need further review. It has decreased from 18.76 Cr. (Mar 2025) to 18.34 Cr., marking a decrease of 0.42 Cr..
- For Total Assets, as of Sep 2025, the value is 45.80 Cr.. The value appears to be declining and may need further review. It has decreased from 46.63 Cr. (Mar 2025) to 45.80 Cr., marking a decrease of 0.83 Cr..
Notably, the Reserves (23.32 Cr.) exceed the Borrowings (10.72 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.31 | 2.25 | -2.59 | -4.48 | -21.92 | -25.76 | -22.72 | -24.20 | -12.10 | -10.93 | -1.41 | -4.19 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68.62 | 62.53 | 80.27 | 82.21 | 79.96 | 94.12 | 82.64 | 103.21 | 64.10 | 66.00 | 68.41 | 57.60 |
| Inventory Days | 110.40 | 107.11 | 137.21 | 139.33 | 126.72 | 201.12 | 198.88 | 224.84 | 228.87 | 234.62 | 191.74 | 194.58 |
| Days Payable | 6.63 | 3.77 | 19.66 | 17.54 | 31.68 | 81.26 | 100.09 | 107.42 | 92.02 | 82.61 | 94.31 | 113.61 |
| Cash Conversion Cycle | 172.39 | 165.87 | 197.82 | 204.00 | 175.00 | 213.98 | 181.42 | 220.64 | 200.95 | 218.01 | 165.84 | 138.57 |
| Working Capital Days | 42.14 | 43.53 | 32.36 | 53.90 | 64.55 | 68.48 | 65.00 | 82.32 | 51.95 | 74.99 | 63.83 | 29.55 |
| ROCE % | 20.35% | 20.81% | 20.55% | 19.21% | 12.62% | 9.86% | 7.65% | 3.78% | 12.64% | 5.52% | 11.27% | 11.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| Diluted EPS (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| Cash EPS (Rs.) | 18.80 | 16.93 | 12.47 | 20.69 | 9.49 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 71.34 | 79.85 | 73.43 | 71.66 | 62.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 71.34 | 79.85 | 73.43 | 71.66 | 62.28 |
| Revenue From Operations / Share (Rs.) | 142.11 | 128.86 | 113.73 | 135.78 | 103.26 |
| PBDIT / Share (Rs.) | 24.71 | 23.19 | 17.83 | 28.42 | 17.53 |
| PBIT / Share (Rs.) | 13.23 | 12.68 | 7.13 | 17.07 | 5.50 |
| PBT / Share (Rs.) | 10.19 | 9.33 | 2.55 | 11.75 | -2.04 |
| Net Profit / Share (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| PBDIT Margin (%) | 17.38 | 17.99 | 15.67 | 20.93 | 16.97 |
| PBIT Margin (%) | 9.30 | 9.84 | 6.27 | 12.57 | 5.32 |
| PBT Margin (%) | 7.16 | 7.23 | 2.24 | 8.65 | -1.97 |
| Net Profit Margin (%) | 5.15 | 4.98 | 1.55 | 6.87 | -2.45 |
| Return on Networth / Equity (%) | 10.26 | 8.04 | 2.41 | 13.03 | -4.07 |
| Return on Capital Employeed (%) | 14.40 | 12.41 | 6.68 | 14.64 | 4.24 |
| Return On Assets (%) | 5.64 | 5.07 | 1.32 | 6.32 | -1.60 |
| Long Term Debt / Equity (X) | 0.20 | 0.20 | 0.39 | 0.56 | 1.02 |
| Total Debt / Equity (X) | 0.48 | 0.33 | 0.61 | 0.82 | 1.07 |
| Asset Turnover Ratio (%) | 1.06 | 0.99 | 0.81 | 0.88 | 0.64 |
| Current Ratio (X) | 1.32 | 1.94 | 1.73 | 1.65 | 1.84 |
| Quick Ratio (X) | 0.74 | 1.12 | 0.88 | 0.86 | 1.12 |
| Inventory Turnover Ratio (X) | 6.47 | 1.73 | 1.46 | 1.74 | 1.72 |
| Interest Coverage Ratio (X) | 8.13 | 6.91 | 3.89 | 5.34 | 2.33 |
| Interest Coverage Ratio (Post Tax) (X) | 3.41 | 2.92 | 1.39 | 2.76 | 0.66 |
| Enterprise Value (Cr.) | 66.54 | 65.94 | 49.05 | 83.11 | 53.76 |
| EV / Net Operating Revenue (X) | 1.30 | 1.29 | 1.09 | 1.55 | 1.32 |
| EV / EBITDA (X) | 7.48 | 7.18 | 6.95 | 7.39 | 7.75 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.09 | 0.70 | 1.12 | 0.67 |
| Price / BV (X) | 2.12 | 1.76 | 1.09 | 2.12 | 1.12 |
| Price / Net Operating Revenue (X) | 1.06 | 1.09 | 0.70 | 1.12 | 0.67 |
| EarningsYield | 0.04 | 0.04 | 0.02 | 0.06 | -0.03 |
After reviewing the key financial ratios for Arex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For Cash EPS (Rs.), as of Mar 25, the value is 18.80. This value is within the healthy range. It has increased from 16.93 (Mar 24) to 18.80, marking an increase of 1.87.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.34. It has decreased from 79.85 (Mar 24) to 71.34, marking a decrease of 8.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.34. It has decreased from 79.85 (Mar 24) to 71.34, marking a decrease of 8.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.11. It has increased from 128.86 (Mar 24) to 142.11, marking an increase of 13.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 23.19 (Mar 24) to 24.71, marking an increase of 1.52.
- For PBIT / Share (Rs.), as of Mar 25, the value is 13.23. This value is within the healthy range. It has increased from 12.68 (Mar 24) to 13.23, marking an increase of 0.55.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.19. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 10.19, marking an increase of 0.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For PBDIT Margin (%), as of Mar 25, the value is 17.38. This value is within the healthy range. It has decreased from 17.99 (Mar 24) to 17.38, marking a decrease of 0.61.
- For PBIT Margin (%), as of Mar 25, the value is 9.30. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 9.30, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 25, the value is 7.16. This value is below the healthy minimum of 10. It has decreased from 7.23 (Mar 24) to 7.16, marking a decrease of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 5.15. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.15, marking an increase of 0.17.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.26. This value is below the healthy minimum of 15. It has increased from 8.04 (Mar 24) to 10.26, marking an increase of 2.22.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.40. This value is within the healthy range. It has increased from 12.41 (Mar 24) to 14.40, marking an increase of 1.99.
- For Return On Assets (%), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 5.64, marking an increase of 0.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.20.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.33 (Mar 24) to 0.48, marking an increase of 0.15.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. It has increased from 0.99 (Mar 24) to 1.06, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.94 (Mar 24) to 1.32, marking a decrease of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.74, marking a decrease of 0.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.47. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 6.47, marking an increase of 4.74.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.13. This value is within the healthy range. It has increased from 6.91 (Mar 24) to 8.13, marking an increase of 1.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.41. This value is within the healthy range. It has increased from 2.92 (Mar 24) to 3.41, marking an increase of 0.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.54. It has increased from 65.94 (Mar 24) to 66.54, marking an increase of 0.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has increased from 1.29 (Mar 24) to 1.30, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.48, marking an increase of 0.30.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.76 (Mar 24) to 2.12, marking an increase of 0.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Arex Industries Ltd:
- Net Profit Margin: 5.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.4% (Industry Average ROCE: 11.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.26% (Industry Average ROE: 12.54%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.2 (Industry average Stock P/E: 79.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Processing/Texturising | 612, GIDC Industrial Estate, Chhatral, Gandhi Nagar Dist. Gujarat 382729 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh A Bilgi | Managing Director & CFO |
| Mr. Neel D Bilgi | Managing Director |
| Mr. Chirag D Bilgi | Managing Director |
| Mr. Pragnesh K Shah | Director |
| Mr. Manoj U Shah | Director |
| Mrs. Rekha Agarwal | Independent Director |
| Mr. Aviv J Divekar | Independent Director |
| Mr. Laxman C Tilani | Director |
| Mr. Sunil Bansibhai Shah | Independent Director |
FAQ
What is the intrinsic value of Arex Industries Ltd?
Arex Industries Ltd's intrinsic value (as of 01 January 2026) is ₹111.95 which is 20.04% lower the current market price of ₹140.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹50.4 Cr. market cap, FY2025-2026 high/low of ₹175/129, reserves of ₹23.32 Cr, and liabilities of ₹45.80 Cr.
What is the Market Cap of Arex Industries Ltd?
The Market Cap of Arex Industries Ltd is 50.4 Cr..
What is the current Stock Price of Arex Industries Ltd as on 01 January 2026?
The current stock price of Arex Industries Ltd as on 01 January 2026 is ₹140.
What is the High / Low of Arex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Arex Industries Ltd stocks is ₹175/129.
What is the Stock P/E of Arex Industries Ltd?
The Stock P/E of Arex Industries Ltd is 20.2.
What is the Book Value of Arex Industries Ltd?
The Book Value of Arex Industries Ltd is 74.8.
What is the Dividend Yield of Arex Industries Ltd?
The Dividend Yield of Arex Industries Ltd is 0.00 %.
What is the ROCE of Arex Industries Ltd?
The ROCE of Arex Industries Ltd is 11.8 %.
What is the ROE of Arex Industries Ltd?
The ROE of Arex Industries Ltd is 9.08 %.
What is the Face Value of Arex Industries Ltd?
The Face Value of Arex Industries Ltd is 10.0.